LEADER 02783nam 2200601 450 001 9910460713803321 005 20200520144314.0 010 $a1-4698-4188-6 010 $a1-4698-4186-X 035 $a(CKB)3710000000529043 035 $a(OCoLC)941029549 035 $a(SSID)ssj0001334269 035 $a(PQKBManifestationID)12570958 035 $a(PQKBTitleCode)TC0001334269 035 $a(PQKBWorkID)11405846 035 $a(PQKB)11339775 035 $a(MiAaPQ)EBC4625043 035 $a(Au-PeEL)EBL4625043 035 $a(CaPaEBR)ebr11292017 035 $a(OCoLC)962449492 035 $a(EXLCZ)993710000000529043 100 $a20161110h20142014 uy 0 101 0 $aeng 135 $aurcn|nnn||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEssentials of pharmacoeconomics /$fKaren L. Rascati 205 $aSecond edition. 210 1$aBaltimore, [Maryland] ;$aPhiladelphia, [Pennsylvania] :$cLippincott Williams & Wilkins,$d2014. 210 4$dİ2014 215 $a1 online resource (xvi, 295 pages) $cillustrations 300 $aIncludes index. 311 $a1-4511-7593-0 320 $aIncludes bibliographical references and index. 327 $a1. Introduction -- 2. Measuring and estimating costs -- 3. Critiquing research articles -- 4. Cost-minimization analysis -- 5. Cost-effectiveness analysis -- 6. Cost-utility analysis -- 7. Cost-benefit analysis -- 8. Health-related quality of life : health status measures -- 9. Decision analysis -- 10. Markov modeling -- 11. Retrospective databases -- 12. Pharmacy services -- 13. International perspective -- 14. Future issues. 330 $a"This new text is designed for a student or practitioner who is unfamiliar with "pharmacoeconomics." It provides a straightforward explanation of the essential pharmacoeconomics topics outlined by The Accreditation Council for Pharmacy Education (ACPE). It defines terminology used in research and covers the application of economic-based evaluation methods for pharmaceutical products and services. Users will find examples of how pharmacoeconomic evaluations relate to decisions that affect patient care and health-related quality of life"--Provided by publisher. 606 $aChemotherapy$xEconomic aspects 606 $aDrugs$xCost effectiveness 606 $aPharmacy$xEconomic aspects 608 $aElectronic books. 615 0$aChemotherapy$xEconomic aspects. 615 0$aDrugs$xCost effectiveness. 615 0$aPharmacy$xEconomic aspects. 676 $a338.433621782 700 $aRascati$b Karen L.$0916623 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910460713803321 996 $aEssentials of pharmacoeconomics$92054900 997 $aUNINA